NasdaqGS - Delayed Quote USD
Lexicon Pharmaceuticals, Inc. (LXRX)
0.6994
+0.0094
+(1.36%)
At close: May 28 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-167,428
-178,780
-161,897
-88,851
-87,017
Investing Cash Flow
135,428
-15,378
-49,943
-71,078
2,110
Financing Cash Flow
-1,606
238,349
187,960
142,209
22,709
End Cash Position
62,888
66,656
22,465
46,345
64,065
Interest Paid Supplemental Data
12,630
12,919
10,057
2,289
799
Capital Expenditure
--
-1,031
-470
-1,326
-1,221
Issuance of Capital Stock
-191
241,322
138,823
94,205
37,084
Issuance of Debt
--
0
49,961
48,868
--
Repayment of Debt
--
--
--
--
-11,700
Repurchase of Capital Stock
--
-1,730
-824
-864
-2,675
Free Cash Flow
-168,459
-179,811
-162,367
-90,177
-88,238
12/31/2021 - 4/7/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CTMX CytomX Therapeutics, Inc.
2.4000
+12.94%
SGMO Sangamo Therapeutics, Inc.
0.4521
-0.22%
EYEN Eyenovia, Inc.
1.6700
+7.74%
PSTV Plus Therapeutics, Inc.
0.2730
-6.22%
IOVA Iovance Biotherapeutics, Inc.
1.7500
+1.16%
RLMD Relmada Therapeutics, Inc.
0.7249
+9.50%
CADL Candel Therapeutics, Inc.
5.94
+6.07%
IBRX ImmunityBio, Inc.
2.4600
-2.77%
APLT Applied Therapeutics, Inc.
0.3771
-1.75%
IVVD Invivyd, Inc.
0.8457
-5.96%